Wichita Asc LP — Billing Profile & Reimbursement Data

WICHITA ASC LP’s code mix is focused on high-acuity cardiovascular procedures consistent with its taxonomy as an Ambulatory Surgical Clinic/Center: top revenue codes include C9600 (percutaneous transcatheter drug‑eluting stent placement), 33249 (implant/replace defibrillator system), 33208 (permanent pacemaker implantation) and large volumes of coronary angiography imaging codes such as 93458. These procedure types indicate the facility operates as a cardiac-focused ASC performing both device implantations/replacements and catheterization/lab imaging services rather than general ambulatory surgery.

Revenue is highly concentrated in a few device and cath lab codes: the precomputed top 3 Medicare codes account for 46.3% of this provider’s total Medicare revenue, with C9600 at 19.0%, 33249 at 15.2%, and 33208 at 12.1% of Medicare revenue. This concentration means changes in utilization, reimbursement, or referral patterns for these specific cardiac device and stent procedures would materially affect overall Medicare revenue.

This provider is effectively single‑payer in scale: lifetime Medicare revenue is $5.2M while there is no Medicaid billing on file. The absence of Medicaid activity makes the organization dependent on Medicare volumes and reimbursement policies rather than a diversified payer mix.

WICHITA ASC LP shows dominant national standing on several device and cath lab codes, indicating outsized market presence for those procedures: 33208 ranks #4 of 3026 providers (100th percentile; extreme outlier), 93458 ranks #2 of 7990 providers (100th percentile; extreme outlier), 33228 ranks #1 of 911 providers (100th percentile; extreme outlier), and 33249 ranks #12 of 1011 providers (99th percentile; extreme outlier). These ranks and percentiles suggest the facility is a major national operator for pacemaker/ICD implantation and cath lab imaging services relative to peers.

Average payments per claim further reflect a device- and implant-heavy case mix: 33249 shows $18409 avg paid/claim and 33264 shows $18407 avg paid/claim, while pacemaker-related codes such as 33208 and 33228 show $5525 and $5406 avg paid/claim respectively. The very high avg paid/claim figures for defibrillator and device-replacement codes are consistent with revenue-driving implant procedures and explain much of the provider’s Medicare revenue concentration.

Operational nuance: procedural volumes are high for imaging supervision and interpretation (93458 with 623 claims at $969 avg paid/claim and 93459 with 96 claims at $971 avg paid/claim), indicating substantial cath lab throughput that complements the device implant business. By contrast, percutaneous coronary intervention code 92920 appears at much lower volume (15 claims, $2202 avg paid/claim), suggesting the ASC’s clinical focus is weighted more toward device work and diagnostic/interpretive cath lab services than routine standalone PCI volume.

Tenure and stability: the NPI was enumerated on 2015-07-16 (~11 years ago), indicating the ASC has been operating for roughly a decade under this identifier. That multi-year presence, combined with concentrated, high-volume national rankings on core cardiac codes, supports the interpretation of an established specialty center rather than a short-term or newly launched operation.

Implications for payers and referral managers: given the facility’s Medicare dependence ($5.2M Medicare revenue, no Medicaid billing) and its extreme-outlier rankings on key device and cath lab codes, payers should treat WICHITA ASC LP as a regionally important referral destination for cardiac device implantation and complex cath lab imaging. The combination of concentrated revenue (46.3% in top 3 codes) and outsized national rankings on those codes means contracting, utilization review, and network-placement decisions should account for both its specialist role and sensitivity to Medicare policy changes affecting high-value device procedures.